2025-03-03 |
2025-03-03 |
S
Sale
|
Chiniara Ellen
Chief Legal Officer
Officer
|
408
-0.5%
31.00
USD 12,650
|
408
-0.5%
|
31.00
|
USD 12,650
|
|
2025-03-03 |
2025-03-03 |
S
Sale
|
Chiniara Ellen
Chief Legal Officer
Officer
|
1,833
-2.2%
30.33
USD 55,590
|
1,833
-2.2%
|
30.33
|
USD 55,590
|
|
2025-03-03 |
2025-03-03 |
S
Sale
|
Jacobs Bruce N.
Chief Financial Officer
Officer
|
1,281
-0.6%
31.00
USD 39,717
|
1,281
-0.6%
|
31.00
|
USD 39,717
|
|
2025-03-03 |
2025-03-03 |
S
Sale
|
Jacobs Bruce N.
Chief Financial Officer
Officer
|
5,754
-2.8%
30.33
USD 174,502
|
5,754
-2.8%
|
30.33
|
USD 174,502
|
|
2025-03-03 |
2025-03-03 |
S
Sale
|
Chadwick Jeremy G
Chief Operating Officer
Officer
|
252
-0.4%
31.00
USD 7,813
|
252
-0.4%
|
31.00
|
USD 7,813
|
|
2025-03-03 |
2025-03-03 |
S
Sale
|
Chadwick Jeremy G
Chief Operating Officer
Officer
|
1,131
-1.6%
30.33
USD 34,300
|
1,131
-1.6%
|
30.33
|
USD 34,300
|
|
2025-03-03 |
2025-03-03 |
S
Sale
|
Gollob Jared
Chief Medical Officer
Officer
|
1,045
-0.9%
31.00
USD 32,400
|
1,045
-0.9%
|
31.00
|
USD 32,400
|
|
2025-03-03 |
2025-03-03 |
S
Sale
|
Gollob Jared
Chief Medical Officer
Officer
|
4,695
-3.7%
30.33
USD 142,386
|
4,695
-3.7%
|
30.33
|
USD 142,386
|
|
2025-01-06 |
2025-01-06 |
PS
Planned sale
|
Chiniara Ellen
Chief Legal Officer
Officer
|
3,129
-5.4%
41.75
USD 130,645
|
3,129
-5.4%
|
41.75
|
USD 130,645
|
|
2024-12-02 |
2024-12-02 |
PS
Planned sale
|
Esposito Pamela
Non-Executive Director
|
2,500
-100.0%
49.00
USD 122,500
|
2,500
-100.0%
|
49.00
|
USD 122,500
|
|
2024-09-17 |
2024-09-17 |
PS
Planned sale
|
Esposito Pamela
Non-Executive Director
|
7,150
-100.0%
48.75
USD 348,581
|
7,150
-100.0%
|
48.75
|
USD 348,581
|
|
2024-09-17 |
2024-09-17 |
PS
Planned sale
|
Esposito Pamela
Non-Executive Director
|
6,350
-47.0%
47.75
USD 303,185
|
6,350
-47.0%
|
47.75
|
USD 303,185
|
|
2024-08-26 |
2024-08-26 |
PS
Planned sale
|
Albers Jeffrey W.
Non-Executive Director
|
5,000
-100.0%
49.10
USD 245,509
|
5,000
-100.0%
|
49.10
|
USD 245,509
|
|
2024-08-22 |
2024-08-20 |
B
Purchase
|
BAKER BROS. ADVISORS LP
Non-Executive Director
|
1
+0.0%
46.41
USD 46
|
1
+0.0%
|
46.41
|
USD 46
|
|
2024-07-16 |
2024-07-16 |
PS
Planned sale
|
Gollob Jared
Chief Medical Officer
Officer
|
9,864
-9.4%
46.10
USD 454,696
|
9,864
-9.4%
|
46.10
|
USD 454,696
|
|
2024-07-16 |
2024-07-16 |
PS
Planned sale
|
Gollob Jared
Chief Medical Officer
Officer
|
13,281
-11.2%
45.59
USD 605,522
|
13,281
-11.2%
|
45.59
|
USD 605,522
|
|
2024-07-16 |
2024-07-15 |
PS
Planned sale
|
Gollob Jared
Chief Medical Officer
Officer
|
16,455
-14.7%
45.15
USD 742,925
|
16,455
-14.7%
|
45.15
|
USD 742,925
|
|
2024-07-09 |
2024-07-09 |
PS
Planned sale
|
Booth Bruce
Non-Executive Director
|
20,238
-2.7%
39.26
USD 794,544
|
20,238
-2.7%
|
39.26
|
USD 794,544
|
|
2024-07-09 |
2024-07-09 |
PS
Planned sale
|
Booth Bruce
Non-Executive Director
|
38,606
-4.9%
38.48
USD 1,485,559
|
38,606
-4.9%
|
38.48
|
USD 1,485,559
|
|
2024-07-09 |
2024-07-09 |
PS
Planned sale
|
Booth Bruce
Non-Executive Director
|
8,769
-1.1%
37.41
USD 328,048
|
8,769
-1.1%
|
37.41
|
USD 328,048
|
|
2024-07-09 |
2024-07-09 |
PS
Planned sale
|
Booth Bruce
Non-Executive Director
|
6,030
-0.8%
36.40
USD 219,492
|
6,030
-0.8%
|
36.40
|
USD 219,492
|
|
2024-07-09 |
2024-07-09 |
PS
Planned sale
|
Booth Bruce
Non-Executive Director
|
5,133
-0.6%
35.57
USD 182,581
|
5,133
-0.6%
|
35.57
|
USD 182,581
|
|
2024-07-09 |
2024-07-09 |
PS
Planned sale
|
Booth Bruce
Non-Executive Director
|
96,386
-2.3%
39.26
USD 3,784,114
|
96,386
-2.3%
|
39.26
|
USD 3,784,114
|
|
2024-07-09 |
2024-07-09 |
PS
Planned sale
|
Booth Bruce
Non-Executive Director
|
183,868
-4.1%
38.48
USD 7,075,241
|
183,868
-4.1%
|
38.48
|
USD 7,075,241
|
|
2024-07-09 |
2024-07-09 |
PS
Planned sale
|
Booth Bruce
Non-Executive Director
|
41,763
-0.9%
37.41
USD 1,562,354
|
41,763
-0.9%
|
37.41
|
USD 1,562,354
|
|
2024-07-09 |
2024-07-09 |
PS
Planned sale
|
Booth Bruce
Non-Executive Director
|
28,718
-0.6%
36.40
USD 1,045,335
|
28,718
-0.6%
|
36.40
|
USD 1,045,335
|
|
2024-07-09 |
2024-07-09 |
PS
Planned sale
|
Booth Bruce
Non-Executive Director
|
24,449
-0.5%
35.57
USD 869,651
|
24,449
-0.5%
|
35.57
|
USD 869,651
|
|
2024-06-14 |
2024-06-13 |
PS
Planned sale
|
Booth Bruce
Non-Executive Director
|
1,770
-0.2%
34.98
USD 61,915
|
1,770
-0.2%
|
34.98
|
USD 61,915
|
|
2024-06-14 |
2024-06-13 |
PS
Planned sale
|
Booth Bruce
Non-Executive Director
|
8,430
-0.2%
34.98
USD 294,881
|
8,430
-0.2%
|
34.98
|
USD 294,881
|
|
2024-06-14 |
2024-06-12 |
PS
Planned sale
|
Booth Bruce
Non-Executive Director
|
420
-0.1%
36.02
USD 15,128
|
420
-0.1%
|
36.02
|
USD 15,128
|
|
2024-06-14 |
2024-06-12 |
PS
Planned sale
|
Booth Bruce
Non-Executive Director
|
2,485
-0.3%
35.35
USD 87,845
|
2,485
-0.3%
|
35.35
|
USD 87,845
|
|
2024-06-14 |
2024-06-12 |
PS
Planned sale
|
Booth Bruce
Non-Executive Director
|
1,997
-0.0%
36.02
USD 71,932
|
1,997
-0.0%
|
36.02
|
USD 71,932
|
|
2024-06-14 |
2024-06-12 |
PS
Planned sale
|
Booth Bruce
Non-Executive Director
|
11,838
-0.3%
35.35
USD 418,473
|
11,838
-0.3%
|
35.35
|
USD 418,473
|
|
2024-06-07 |
2024-06-07 |
PS
Planned sale
|
Horobin Joanna
Non-Executive Director
|
6,313
-100.0%
33.11
USD 209,005
|
6,313
-100.0%
|
33.11
|
USD 209,005
|
|
2024-06-07 |
2024-06-07 |
PS
Planned sale
|
Horobin Joanna
Non-Executive Director
|
2,187
-25.7%
32.65
USD 71,395
|
2,187
-25.7%
|
32.65
|
USD 71,395
|
|
2024-05-23 |
2024-05-23 |
S
Sale
|
Chadwick Jeremy G
Chief Operating Officer
Officer
|
2,575
-5.5%
34.99
USD 90,105
|
2,575
-5.5%
|
34.99
|
USD 90,105
|
|
2024-03-15 |
2024-03-15 |
PS
Planned sale
|
Booth Bruce
Non-Executive Director
|
329
-0.0%
41.23
USD 13,565
|
329
-0.0%
|
41.23
|
USD 13,565
|
|
2024-03-15 |
2024-03-15 |
PS
Planned sale
|
Booth Bruce
Non-Executive Director
|
10,411
-1.3%
40.62
USD 422,895
|
10,411
-1.3%
|
40.62
|
USD 422,895
|
|
2024-03-15 |
2024-03-15 |
PS
Planned sale
|
Booth Bruce
Non-Executive Director
|
1,714
-0.2%
39.31
USD 67,377
|
1,714
-0.2%
|
39.31
|
USD 67,377
|
|
2024-03-15 |
2024-03-15 |
PS
Planned sale
|
Booth Bruce
Non-Executive Director
|
1,593
-0.0%
41.23
USD 65,679
|
1,593
-0.0%
|
41.23
|
USD 65,679
|
|
2024-03-15 |
2024-03-15 |
PS
Planned sale
|
Booth Bruce
Non-Executive Director
|
49,591
-1.1%
40.62
USD 2,014,386
|
49,591
-1.1%
|
40.62
|
USD 2,014,386
|
|
2024-03-15 |
2024-03-15 |
PS
Planned sale
|
Booth Bruce
Non-Executive Director
|
8,126
-0.2%
39.31
USD 319,433
|
8,126
-0.2%
|
39.31
|
USD 319,433
|
|
2024-03-15 |
2024-03-14 |
PS
Planned sale
|
Booth Bruce
Non-Executive Director
|
154
-0.0%
41.51
USD 6,393
|
154
-0.0%
|
41.51
|
USD 6,393
|
|
2024-03-15 |
2024-03-14 |
PS
Planned sale
|
Booth Bruce
Non-Executive Director
|
2,233
-0.3%
40.66
USD 90,794
|
2,233
-0.3%
|
40.66
|
USD 90,794
|
|
2024-03-15 |
2024-03-14 |
PS
Planned sale
|
Booth Bruce
Non-Executive Director
|
7,292
-0.9%
39.73
USD 289,711
|
7,292
-0.9%
|
39.73
|
USD 289,711
|
|
2024-03-15 |
2024-03-14 |
PS
Planned sale
|
Booth Bruce
Non-Executive Director
|
781
-0.0%
41.51
USD 32,419
|
781
-0.0%
|
41.51
|
USD 32,419
|
|
2024-03-15 |
2024-03-14 |
PS
Planned sale
|
Booth Bruce
Non-Executive Director
|
10,846
-0.2%
40.66
USD 440,998
|
10,846
-0.2%
|
40.66
|
USD 440,998
|
|
2024-03-15 |
2024-03-14 |
PS
Planned sale
|
Booth Bruce
Non-Executive Director
|
34,473
-0.7%
39.73
USD 1,369,612
|
34,473
-0.7%
|
39.73
|
USD 1,369,612
|
|
2024-03-13 |
2024-03-13 |
PS
Planned sale
|
Atlas Venture Fund X, L.P.
Large shareholder
|
1,386
-0.2%
42.84
USD 59,376
|
1,386
-0.2%
|
42.84
|
USD 59,376
|
|
2024-03-13 |
2024-03-13 |
PS
Planned sale
|
Atlas Venture Fund X, L.P.
Large shareholder
|
22,779
-2.7%
42.19
USD 961,046
|
22,779
-2.7%
|
42.19
|
USD 961,046
|
|
2024-03-13 |
2024-03-13 |
PS
Planned sale
|
Atlas Venture Fund X, L.P.
Large shareholder
|
6,686
-0.1%
42.84
USD 286,428
|
6,686
-0.1%
|
42.84
|
USD 286,428
|
|
2024-03-13 |
2024-03-13 |
PS
Planned sale
|
Atlas Venture Fund X, L.P.
Large shareholder
|
108,404
-2.3%
42.19
USD 4,573,565
|
108,404
-2.3%
|
42.19
|
USD 4,573,565
|
|
2024-03-13 |
2024-03-13 |
PS
Planned sale
|
Booth Bruce
Non-Executive Director
|
1,386
-0.2%
42.84
USD 59,376
|
1,386
-0.2%
|
42.84
|
USD 59,376
|
|
2024-03-13 |
2024-03-13 |
PS
Planned sale
|
Booth Bruce
Non-Executive Director
|
22,779
-2.7%
42.19
USD 961,046
|
22,779
-2.7%
|
42.19
|
USD 961,046
|
|
2024-03-13 |
2024-03-13 |
PS
Planned sale
|
Booth Bruce
Non-Executive Director
|
6,686
-0.1%
42.84
USD 286,428
|
6,686
-0.1%
|
42.84
|
USD 286,428
|
|
2024-03-13 |
2024-03-13 |
PS
Planned sale
|
Booth Bruce
Non-Executive Director
|
108,404
-2.3%
42.19
USD 4,573,565
|
108,404
-2.3%
|
42.19
|
USD 4,573,565
|
|
2024-03-13 |
2024-03-12 |
PS
Planned sale
|
Atlas Venture Fund X, L.P.
Large shareholder
|
1,819
-0.2%
42.52
USD 77,344
|
1,819
-0.2%
|
42.52
|
USD 77,344
|
|
2024-03-13 |
2024-03-12 |
PS
Planned sale
|
Atlas Venture Fund X, L.P.
Large shareholder
|
26,452
-3.0%
41.94
USD 1,109,397
|
26,452
-3.0%
|
41.94
|
USD 1,109,397
|
|
2024-03-13 |
2024-03-12 |
PS
Planned sale
|
Atlas Venture Fund X, L.P.
Large shareholder
|
8,581
-0.2%
42.52
USD 364,864
|
8,581
-0.2%
|
42.52
|
USD 364,864
|
|
2024-03-13 |
2024-03-12 |
PS
Planned sale
|
Atlas Venture Fund X, L.P.
Large shareholder
|
126,066
-2.6%
41.94
USD 5,287,208
|
126,066
-2.6%
|
41.94
|
USD 5,287,208
|
|
2024-03-13 |
2024-03-12 |
PS
Planned sale
|
Booth Bruce
Non-Executive Director
|
1,819
-0.2%
42.52
USD 77,344
|
1,819
-0.2%
|
42.52
|
USD 77,344
|
|
2024-03-13 |
2024-03-12 |
PS
Planned sale
|
Booth Bruce
Non-Executive Director
|
26,452
-3.0%
41.94
USD 1,109,397
|
26,452
-3.0%
|
41.94
|
USD 1,109,397
|
|
2024-03-13 |
2024-03-12 |
PS
Planned sale
|
Booth Bruce
Non-Executive Director
|
8,581
-0.2%
42.52
USD 364,864
|
8,581
-0.2%
|
42.52
|
USD 364,864
|
|
2024-03-13 |
2024-03-12 |
PS
Planned sale
|
Booth Bruce
Non-Executive Director
|
126,066
-2.6%
41.94
USD 5,287,208
|
126,066
-2.6%
|
41.94
|
USD 5,287,208
|
|
2024-03-13 |
2024-03-11 |
PS
Planned sale
|
Atlas Venture Fund X, L.P.
Large shareholder
|
1,045
-0.1%
43.42
USD 45,374
|
1,045
-0.1%
|
43.42
|
USD 45,374
|
|
2024-03-13 |
2024-03-11 |
PS
Planned sale
|
Atlas Venture Fund X, L.P.
Large shareholder
|
7,837
-0.9%
42.77
USD 335,188
|
7,837
-0.9%
|
42.77
|
USD 335,188
|
|
2024-03-13 |
2024-03-11 |
PS
Planned sale
|
Atlas Venture Fund X, L.P.
Large shareholder
|
5,122
-0.1%
43.42
USD 222,397
|
5,122
-0.1%
|
43.42
|
USD 222,397
|
|
2024-03-13 |
2024-03-11 |
PS
Planned sale
|
Atlas Venture Fund X, L.P.
Large shareholder
|
37,180
-0.7%
42.77
USD 1,590,189
|
37,180
-0.7%
|
42.77
|
USD 1,590,189
|
|
2024-03-13 |
2024-03-11 |
PS
Planned sale
|
Booth Bruce
Non-Executive Director
|
1,045
-0.1%
43.42
USD 45,374
|
1,045
-0.1%
|
43.42
|
USD 45,374
|
|
2024-03-13 |
2024-03-11 |
PS
Planned sale
|
Booth Bruce
Non-Executive Director
|
7,837
-0.9%
42.77
USD 335,188
|
7,837
-0.9%
|
42.77
|
USD 335,188
|
|
2024-03-13 |
2024-03-11 |
PS
Planned sale
|
Booth Bruce
Non-Executive Director
|
5,122
-0.1%
43.42
USD 222,397
|
5,122
-0.1%
|
43.42
|
USD 222,397
|
|
2024-03-13 |
2024-03-11 |
PS
Planned sale
|
Booth Bruce
Non-Executive Director
|
37,180
-0.7%
42.77
USD 1,590,189
|
37,180
-0.7%
|
42.77
|
USD 1,590,189
|
|
2024-03-04 |
2024-03-04 |
S
Sale
|
Gollob Jared
Chief Medical Officer
Officer
|
216
-0.2%
43.26
USD 9,343
|
216
-0.2%
|
43.26
|
USD 9,343
|
|
2024-03-04 |
2024-03-04 |
S
Sale
|
Gollob Jared
Chief Medical Officer
Officer
|
1,106
-1.1%
42.39
USD 46,886
|
1,106
-1.1%
|
42.39
|
USD 46,886
|
|
2024-03-04 |
2024-03-04 |
S
Sale
|
Gollob Jared
Chief Medical Officer
Officer
|
2,022
-2.0%
41.41
USD 83,738
|
2,022
-2.0%
|
41.41
|
USD 83,738
|
|